U.S. Army Offers $1.4 Million for Early-Career Ovarian Cancer Clinical Trial Investigators
Grants
Copyright © Targeted News Service, 2025
Copyright © Targeted News Service, 2025
2025-04-24
By Aliza Qamar
WASHINGTON, April 24 -- The U.S. Army has announced a focused funding opportunity, allocating $1.4 million through the Ovarian Cancer Clinical Trial Academy (OCCTA) - Early-Career Investigator Award.
This grant aims to cultivate the next generation of researchers dedicated to developing effective treatments and cures for ovarian cancer through clinical trials.
Administered by the Department of the Army under the U.S. Army Medical Research Acquisition Activity (USAMRAA) . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, April 24 -- The U.S. Army has announced a focused funding opportunity, allocating $1.4 million through the Ovarian Cancer Clinical Trial Academy (OCCTA) - Early-Career Investigator Award.
This grant aims to cultivate the next generation of researchers dedicated to developing effective treatments and cures for ovarian cancer through clinical trials.
Administered by the Department of the Army under the U.S. Army Medical Research Acquisition Activity (USAMRAA) . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com